Inovio Pharmaceuticals Inc. Stock Advances 10.2%, Outperforms Peers
Dow Jones2026/08/10 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. surged 10.2% to $0.74 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,605.36 and Dow Jones Industrial Average falling 0.1% to 53,975.98.
The stock's rise snapped a two-day losing streak.
Inovio Pharmaceuticals Inc. closed 75.3% below its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its peers, as Johnson & Johnson rose 1.0% to $261.81, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.08% to $27.05.
Trading volume totaled 3.3 million, compared to the 50-day average of 2.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 10, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ambiq Micro director Ker Zhang sells 185 shares worth $10,530.2
Granite Construction Wins $23.7 Million Road Rehabilitation Project in Glacier National Park
Circle Internet Group Insider Sold Shares Worth $2,677,266, According to a Recent SEC Filing
Pitney Bowes EVP Deborah Pfeiffer sells 20,000 shares worth $342,240
Crypto prices
More
